Article
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.
PloS one - 1 Jan 2021
Schrörs Barbara, Riesgo-Ferreiro Pablo, Sorn Patrick, Gudimella Ranganath, Bukur Thomas, Rösler Thomas, Löwer Martin, Sahin Ugur
Abstract excerpt
Due to the widespread of the COVID-19 pandemic, the SARS-CoV-2 genome is evolving in diverse human populations. Several studies already reported different strains and an increase in the mutation rate. Particularly, mutations in SARS-CoV-2 spike-glycoprotein are of great interest as it mediates infection in human and recently approved mRNA vaccines are designed to induce immune responses against it. We analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
